Skip to main contentSkip to navigation
Sirius Investors
PharmChem, Inc.

PharmChem, Inc.

PCHM
OTCHealthcare

PharmChem, Inc. (PCHM) Investment Research Dashboard

About PharmChem, Inc. (PCHM) stock analysis

Get live PCHM stock price $3.75, comprehensive PharmChem, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time PCHM stock data and investment insights.

3.75
0.27%Today
Market Cap
21.95M
Volume
30.42K
52W High
3.98
52W Low
2.95

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

PharmChem, Inc. manufactures and distributes the PharmChek Sweat Patch, a product designed for detecting the presence of illicit substances. This patch uses sweat as its sample source, offering an innovative alternative to conventional urine drug tes...

Company Information

CEO
Thompson Clark CPA
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
9

Contact Information

Address
2411 East Loop 820 North
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.67) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for PharmChem, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for PharmChem, Inc.
  • Investors should consider how PharmChem, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

21.95M

P/E Ratio (TTM)

-0.02

Beta

0.67

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

78/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+3.1%+4.3%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.7%+1.3%+1.6%24.1
78/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.7%+2.9%22.2
74/100⭐⭐⭐⭐⭐
Consumer Defensive-0.2%+1.8%+0.7%29.7
64/100⭐⭐⭐⭐
Basic Materials+0.4%+1.2%-0.2%25.2
61/100⭐⭐⭐⭐
Real Estate-0.5%+0.0%-2.5%29.2
43/100⭐⭐⭐
Energy-2.1%-3.7%-4.1%19.1
39/100⭐⭐
Utilities-1.0%+0.0%-4.4%26.8
37/100⭐⭐
Industrials+0.6%+0.4%-9.9%30.1
23/100
Consumer Cyclical+0.5%-1.5%-5.8%43.0
18/100
Technology+0.6%-1.6%-7.2%40.7
15/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.